Spironolactone After Liver Transplant
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 8/2/2017 |
| Start Date: | December 2014 |
| End Date: | December 2020 |
| Contact: | Mark W Russo, MD, MPH |
| Email: | mark.russo@carolinashealthcare.org |
| Phone: | 704-355-6649 |
Spironolactone to Prevent or Delay CNI Toxicity in Liver Transplant Recipients
To study spironolactone to prevent CNI kidney injury.
Inclusion Criteria:
- liver transplant
Exclusion Criteria:
- dual organ transplant
We found this trial at
1
site
Click here to add this to my saved trials
